Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giulia Caron

Showing results (31-40 of 95) with videos related to

Pageof 10
Sort By:
Drug Discovery Today|January 29, 2020
Flexibility in early drug discovery: focus on the beyond-Rule-of-5 chemical spaceGiulia Caron, Vito Digiesi, Sara Solaro, et al.
Journal of Computer-Aided Molecular Design|January 12, 2015
Prediction and interpretation of the lipophilicity of small peptidesAlessia Visconti, Giuseppe Ermondi, Giulia Caron, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 21, 2013
The Block Relevance (BR) analysis supports the dominating effect of solutes hydrogen bond acidity on ΔlogP(oct-tol)Giuseppe Ermondi, Alessia Visconti, Roberto Esposito, et al.
International Journal of Pharmaceutics|April 25, 2015
Profile of the intermolecular forces governing the interaction of drugs with mucinGiulia Caron, Sonja Visentin, Carlotta Pontremoli, et al.
Drug Discovery Today|December 27, 2021
AI-based protein structure databases have the potential to accelerate rare diseases research: AlphaFoldDB and the case of IAHSP/AlsinMatteo Rossi Sebastiano, Giuseppe Ermondi, Shinji Hadano, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|October 12, 2020
Into the first biomimetic sphingomyelin stationary phase: Suitability in drugs' biopharmaceutic profiling and block relevance analysis of selectivityGiacomo Russo, Giuseppe Ermondi, Giulia Caron, et al.
ACS Medicinal Chemistry Letters|July 15, 2021
Rational Control of Molecular Properties Is Mandatory to Exploit the Potential of PROTACs as Oral DrugsGiuseppe Ermondi, Diego Garcia Jimenez, Matteo Rossi Sebastiano, et al.
Bioorganic & Medicinal Chemistry|February 16, 2023
Ionization and lipophilicity in nonpolar media mimicking the cell membrane interiorMaura Vallaro, Giuseppe Ermondi, Jaan Saame, et al.
ADMET & DMPK|March 18, 2022
Solubility prediction in the bRo5 chemical space: where are we right now?Giuseppe Ermondi, Vasanthanathan Poongavanam, Maura Vallaro, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|February 24, 2020
Updating the portfolio of physicochemical descriptors related to permeability in the beyond the rule of 5 chemical spaceGiuseppe Ermondi, Maura Vallaro, Gilles Goetz, et al.
Pageof 10

Showing results (31-40 of 95) with videos related to

Sort By:
Pageof 10
Drug Discovery Today|January 29, 2020
Flexibility in early drug discovery: focus on the beyond-Rule-of-5 chemical spaceGiulia Caron, Vito Digiesi, Sara Solaro, et al.
Journal of Computer-Aided Molecular Design|January 12, 2015
Prediction and interpretation of the lipophilicity of small peptidesAlessia Visconti, Giuseppe Ermondi, Giulia Caron, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 21, 2013
The Block Relevance (BR) analysis supports the dominating effect of solutes hydrogen bond acidity on ΔlogP(oct-tol)Giuseppe Ermondi, Alessia Visconti, Roberto Esposito, et al.
International Journal of Pharmaceutics|April 25, 2015
Profile of the intermolecular forces governing the interaction of drugs with mucinGiulia Caron, Sonja Visentin, Carlotta Pontremoli, et al.
Drug Discovery Today|December 27, 2021
AI-based protein structure databases have the potential to accelerate rare diseases research: AlphaFoldDB and the case of IAHSP/AlsinMatteo Rossi Sebastiano, Giuseppe Ermondi, Shinji Hadano, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|October 12, 2020
Into the first biomimetic sphingomyelin stationary phase: Suitability in drugs' biopharmaceutic profiling and block relevance analysis of selectivityGiacomo Russo, Giuseppe Ermondi, Giulia Caron, et al.
ACS Medicinal Chemistry Letters|July 15, 2021
Rational Control of Molecular Properties Is Mandatory to Exploit the Potential of PROTACs as Oral DrugsGiuseppe Ermondi, Diego Garcia Jimenez, Matteo Rossi Sebastiano, et al.
Bioorganic & Medicinal Chemistry|February 16, 2023
Ionization and lipophilicity in nonpolar media mimicking the cell membrane interiorMaura Vallaro, Giuseppe Ermondi, Jaan Saame, et al.
ADMET & DMPK|March 18, 2022
Solubility prediction in the bRo5 chemical space: where are we right now?Giuseppe Ermondi, Vasanthanathan Poongavanam, Maura Vallaro, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|February 24, 2020
Updating the portfolio of physicochemical descriptors related to permeability in the beyond the rule of 5 chemical spaceGiuseppe Ermondi, Maura Vallaro, Gilles Goetz, et al.
Pageof 10